NCT03504761View on ClinicalTrials.gov

ClariCore System Used in Transrectal Ultrasound Guided Prostate Biopsy for Real-Time Tissue Evaluation

NAUnknownINTERVENTIONAL
Enrollment

325

Participants

Timeline

Start Date

April 25, 2018

Primary Completion Date

January 31, 2020

Study Completion Date

December 31, 2020

Conditions
Cellular Diagnosis, Prostate Cancer
Interventions
DEVICE

ClariCore Optical Biopsy System

Demonstrate the efficacy and safety of the ClariCore System in obtaining prostate biopsies utilizing real-time tissue classification.

Trial Locations (6)

10016

RECRUITING

NYU Langone Urology Associates, New York

10021

NOT_YET_RECRUITING

Memorial Sloan-Kettering Cancer Center, New York

21287

NOT_YET_RECRUITING

Brady Urological Institute, Johns Hopkins Hospital, Baltimore

29572

RECRUITING

Carolina Urologic Research Center, Myrtle Beach

78229

NOT_YET_RECRUITING

Urology of San Antonio, San Antonio

80211

RECRUITING

The Urology Center of Colorado, Denver

Sponsors
All Listed Sponsors
lead

Precision Biopsy, Inc.

INDUSTRY

NCT03504761 - ClariCore System Used in Transrectal Ultrasound Guided Prostate Biopsy for Real-Time Tissue Evaluation | Biotech Hunter | Biotech Hunter